STAT3 and breast cancer: Meanwhile, there is also evidence that IL-32β activates the VEGF-STAT3 signal pathway, thereby promoting breast cancer cell migration [19], while inhibits NF-κB and STAT3 signaling pathways to suppress tumor growth [20].